Chronic myeloid leukemia (CML) is a hematopoietic stem/progenitor cell disorder in which BCR-ABL oncoprotein leads to a progressive block of differentiation and increased genetic instability [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.